Title : NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.

Pub. Date : 2012 Sep

PMID : 22296034






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes. repaglinide neuronal differentiation 1 Homo sapiens
2 AIMS: We aimed to determine whether NeuroD1/BETA2 and PAX4 polymorphisms were associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetes mellitus (T2DM) patients. repaglinide neuronal differentiation 1 Homo sapiens
3 AIMS: We aimed to determine whether NeuroD1/BETA2 and PAX4 polymorphisms were associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetes mellitus (T2DM) patients. repaglinide neuronal differentiation 1 Homo sapiens
4 CONCLUSIONS: The NeuroD1/BETA2 and PAX4 polymorphisms were substantially associated with plasma glucose level after repaglinide monotherapy. repaglinide neuronal differentiation 1 Homo sapiens
5 CONCLUSIONS: The NeuroD1/BETA2 and PAX4 polymorphisms were substantially associated with plasma glucose level after repaglinide monotherapy. repaglinide neuronal differentiation 1 Homo sapiens